Authorities in Jalisco, Mexico, closed one clandestine laboratory and two pharmacies for producing and distributing counterfeit medications [1].
The operation targets a public health risk created by the sale of fake treatments. Counterfeit pharmaceuticals can lack active ingredients or contain harmful substances, potentially leading to treatment failure or death for patients relying on these drugs.
The Jalisco State Attorney General's Office and the Commission for the Protection against Sanitary Risks of Jalisco, known as Coprisjal, coordinated the raids in Zapopan [1]. The agencies identified a network that manufactured and sold these falsified products through the targeted pharmacies [1].
During the enforcement actions, officials shuttered one illegal laboratory and two pharmacies [1]. While reports vary on the specific agency that issued the formal health alert—with some citing the federal agency Cofepris and others citing the state-level Coprisjal—the operational closures were executed by state authorities [1].
The crackdown follows an investigation into the distribution chain of these medications. By removing the production site and the retail points of sale, officials aim to prevent further circulation of the dangerous products within the community [1].
“Officials in Jalisco closed one illegal laboratory and two pharmacies for distributing counterfeit medications.”
This operation highlights the ongoing struggle against the illicit pharmaceutical trade in Mexico, where clandestine labs often bypass safety regulations to produce low-cost, fake alternatives to essential medicines. The involvement of both the state prosecutor and health regulators suggests a coordinated effort to dismantle the financial and logistical infrastructure of the network rather than simply treating it as a regulatory violation.
